drugset / Trial / NCT04982809
Cost-effectiveness Analysis of Three Corticosteroids in ILDs
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This was a 3 months prospective, open label, and parallel study to test the efficacy of 3 different corticosteroids in the management of interstitial lung diseases. Followed by a pharmacoeconomic analysis to find which regimen (betamethasone, dexamethasone or prednisolone) is the most cost-effective.
Timeline
- Start
- 2018-07-01
- Primary completion
- 2020-03-15
- Completion
- 2020-03-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Betamethasone | Other / unclassified | — | Intramuscular |
| Comparator | Dexamethasone | Small molecule | — | Intravenous |
| Comparator | Prednisolone | Other / unclassified | 15 mg | Oral |
| Comparator | Prednisolone | Other / unclassified | 20 mg | Oral |